We examined the influence of dietary fatty acid (FA) classes on the expression of protein kinase C (PKC) δ and ε in relation to the cardioprotective effects of chronic intermittent hypoxia (CIH). Adult male Wistar rats were fed a nonfat diet enriched with 10% lard (saturated FA [SFA]), fish oil (n-3 polyunsaturated FA [n-3 PUFA]), or corn oil (n-6 PUFA) for 10 weeks. After 4 weeks on the diet, each group was divided into two subgroups that were either exposed to CIH in a barochamber (7000 m, 8 hrs/ day) or kept at normoxia for an additional 5–6 weeks. A FA phospholipid profile and Western blot analysis of PKC were performed in left ventricles. Infarct size was assessed in anesthetized animals subjected to 20-min coronary artery occlusion and 3-hr reperfusion. CIH decreased the n-6/n-3 PUFA ratio in all groups by 23% independently of the initial value set by various diets. The combination of n-3 diet and CIH had a stronger antiarrhythmic effect during reperfusion than the n-3 diet alone; this effect was less pronounced in rats fed the n-6 diet. The normoxic n-6 group exhibited smaller infarctions (by 22%) than the n-3 group. CIH decreased the infarct size in n-3 and SFA groups (by 20% and 23%, respectively) but not in the n-6 group. Unlike PKCε, the abundance of PKCδ in the myocardial particulate fraction was increased by CIH except for the n-6 group. Myocardial infarct size was negatively correlated (r = − 0.79) with the abundance of PKCδ in the particulate fraction. We conclude that lipid diets modify the infarct size–limiting effect of CIH by a mechanism that involves the PKCδ-dependent pathway.
Get full access to this article
View all access options for this article.
References
1.
Demaison L, Moreau D. Dietary n-3 polyunsaturated fatty acids and coronary heart disease-related mortality: a possible mechanism of action. Cell Mol Life Sci59:463–477, 2002.
2.
Leaf A, Xiao YF, Kang JX, Billman GE. Prevention of sudden cardiac death by n-3 polyunsaturated fatty acids. Pharmacol Ther98:355–377, 2003.
3.
Lepran I, Nemecz G, Koltai M, Szekeres L. Effect of a linoleic acid-rich diet on the acute phase of coronary occlusion in conscious rats: influence of indomethacin and aspirin. J Cardiovasc Pharmacol3:847–853, 1981.
4.
McLennan PL, Abeywardena MY, Charnock JS. Influence of dietary lipids on arrhythmias and infarction after coronary artery ligation in rats. Can J Physiol Pharmacol63:1411–1417, 1985.
5.
McLennan PL. Relative effects of dietary saturated, monounsaturated, and polyunsaturated fatty acids on cardiac arrhythmias in rats. Am J Clin Nutr57:207–212, 1993.
6.
Demaison L, Sergiel JP, Moreau D, Grynberg A. Influence of the phospholipid n-6/n-3 polyunsaturated fatty acid ratio on the mitochondrial oxidative metabolism before and after myocardial ischemia. Biochim Biophys Acta1227:53–59, 1994.
7.
Zhu BQ, Sievers RE, Sun YP, Morse-Fisher N, Parmley WW, Wolfe CL. Is the reduction of myocardial infarct size by dietary fish oil the result of altered platelet function? Am Heart J 127:744–755, 1994.
8.
Billman GE, Kang JX, Leaf A. Prevention of sudden cardiac death by dietary pure omega-3 polyunsaturated fatty acids in dogs. Circulation99:2452–2457, 1999.
9.
Pepe S, McLennan PL. Dietary fish oil confers direct antiarrhythmic properties on the myocardium of rats. J Nutr126:34–42, 1996.
10.
Mozaffarian D, Ascherio A, Hu FB, Stampfer MJ, Willett WC, Siscovick DS, Rimm EB. Interplay between different polyunsaturated fatty acids and risk of coronary heart disease in men. Circulation111:157–164, 2005.
11.
Kolar F, Ostadal B. Molecular mechanisms of cardiac protection by adaptation to chronic hypoxia. Physiol Res53(Suppl 1):S3–S13, 2004.
12.
Zong P, Setty S, Sun W, Martinez R, Tune JD, Ehrenbourg IV, Tkatchouk EN, Mallet RT, Downey HF. Intermittent hypoxic training protects canine myocardium from infarction. Exp Biol Med229:806–812, 2004.
13.
Zhong N, Zhang Z, Fang Q-Z, Zhou Z-N. Intermittent hypoxia exposure-induced heat-shock protein 70 expression increases resistance of rat heart to ischemic injury. Acta Pharmacol Sin21:467–472, 2000.
14.
Neckar J, Ostadal B, Kolar F. Myocardial infarct size-limiting effect of chronic hypoxia persists for five weeks of normoxic recovery. Physiol Res53:621–628, 2004.
15.
Fitzpatrick C, Shi Y, Hutchins WC, Su J, Gross GJ, Ostadal B, Tweddell JS, Baker JE. Cardioprotection in chronically hypoxic rabbits persists on exposure to normoxia: role of NOS and KATP channels. Am J Physiol Heart Circ Physiol288:H62–H68, 2005.
16.
Yellon DM, Downey JM. Preconditioning the myocardium: from cellular physiology to clinical cardiology. Physiol Rev83:1113–1151, 2003.
17.
Kolar F, Jezkova J, Balkova P, Breh J, Neckar J, Novak F, Novakova O, Tomasova H, Srbova M, Ostadal B, Wilhelm J, Herget J. Role of oxidative stress in PKC-δ up-regulation and cardioprotection induced by chronic intermittent hypoxia. Am J Physiol Heart Circ Physiol292: H224–H230, 2007.
18.
Neckar J, Markova I, Novak F, Novakova O, Szarszoi O, Ostadal B, Kolar F. Increased expression and altered subcellular distribution of PKC isoform δ in chronically hypoxic rat myocardium: involvement in cardioprotection. Am J Physiol Heart Circ Physiol288:H1566–H572, 2005.
19.
Hlavackova M, Neckar J, Nevelikova L, Novakova O, Kolar F, Musters RJP, Novak F. Expression and subcellular redistribution of PKC isoforms in chronically hypoxic rat heart (abstract). J Mol Cell Cardiol40:930, 2006.
20.
Jezkova J, Novakova O, Kolar F, Tvrzicka E, Neckar J, Novak F. Chronic hypoxia alters fatty acid composition of phospholipids in right and left ventricular myocardium. Mol Cell Biochem232:49–56, 2002.
21.
Yang BC, Saldeen TG, Bryant JL, Nichols WW, Mehta JL. Long-term dietary fish oil supplementation protects against ischemia-reperfusion-induced myocardial dysfunction in isolated rat hearts. Am Heart J126:1287–1292, 1993.
22.
Neckar J, Papousek F, Novakova O, Ostadal B, Kolar F. Cardioprotective effects of chronic hypoxia and preconditioning are not additive. Basic Res Cardiol97:161–167, 2002.
23.
Folch J, Lees M, Sloan-Stanley GH. A simple method for the isolation and purification of total lipids from animal tissue. J Biol Chem226:497–509, 1957.
24.
Peterson GL. A simplification of the protein assay method of Lowry et al. which is more generally applicable. Anal Biochem83:346–356, 1977.
25.
Walker MJA, Curtis MJ, Hearse DJ, Campbell RWF, Jansen MJ, Yellon DM, Cobbe SM, Coker SJ, Harness JB, Harron DW, Higgins AJ, Julian DG, Lab MJ, Manning AS, Northover BJ, Parratt JR, Riemersma RA, Riva E, Russell CD, Sheridan DJ, Wislow E, Woodward B. The Lambeth Convention: guidelines for study of arrhythmias in ischaemia, infarction and reperfusion. Cardiovasc Res22:447–455, 1988.
26.
Culp BR, Lands WE, Lucches BR, Pitt B, Romson J. The effect of dietary supplementation of fish oil on experimental myocardial infarction. Prostaglandins20:1021–1031, 1980.
27.
Hock CE, Holahan MA, Reibel DK. Effect of dietary fish oil on myocardial phospholipids and myocardial ischemic damage. Am J Physiol252:H554–H560, 1987.
28.
Force T, Malis CD, Guerrero JL, Varadarajan GS, Bonventre JV, Weber PC, Leaf A. n-3 fatty acids increase postischemic blood flow but do not reduce myocardial necrosis. Am J Physiol257:H1204–H1210, 1989.
29.
Farooqui AA, Horrocks LA, Farooqui T. Deacylation and reacylation of neural membrane glycerophospholipids. J Mol Neurosci14:123–135, 2000.
30.
Archer SL, Johnson GJ, Gebhard RL, Castleman WL, Levine AS, Westcott JY, Voelkel NF, Nelson DP, Weir EK. Effect of dietary fish oil on lung lipid profile and hypoxic pulmonary hypertension. J Appl Physiol66:1662–1673, 1989.
31.
Abeywardena MY, Charnock JS. Dietary lipid modification of myocardial eicosanoids following ischemia and reperfusion in the rat. Lipids30:1151–1156, 1995.
32.
Isensee H, Jacob R. Differential effects of various oil diets on the risk of cardiac arrhythmias in rats. J Cardiovasc Risk1:353–359, 1994.
33.
Szarszoi O, Asemu G, Ostadal B, Kolar F. The role of reactive oxygen species and nitric oxide in ischemia/reperfusion injury of chronically hypoxic rats heart (abstract). Eur J Heart Failure Suppl2:53, 2003.
34.
Ahotupa M, Bereziat JC, Mantyla E, Bartsch H. Dietary fat- and phenobarbital-induced alterations in hepatic antioxidant functions of mice. Carcinogenesis14:1225–1228, 1993.
35.
Pepe S. Effect of dietary polyunsaturated fatty acids on age-related changes in cardiac mitochondrial membranes. Exp Gerontol40:751–758, 2005.
36.
L’Abbe MR, Trick KD, Beare-Rogers JL. Dietary (n-3) fatty acids affect rat heart, liver and aorta protective enzyme activities and lipid peroxidation. J Nutr121:1331–1340, 1991.
37.
Palozza P, Sgarlata E, Luberto C, Piccioni E, Anti M, Marra G, Armelao F, Franceschelli P, Bartoli GM. n-3 fatty acids induce oxidative modifications in human erythrocytes depending on dose and duration of dietary supplementation. Am J Clin Nutr64:297–304, 1996.
38.
Karmazyn M, Horackova M, Murphy MG. Effects of dietary cod liver oil on fatty-acid composition and calcium transport in isolated adult rat ventricular myocytes and on the response of isolated hearts to ischemia and reperfusion. Can J Physiol Pharmacol65:201–209, 1987.
39.
Sergiel JP, Martine L, Raederstorff D, Grynberg A, Demaison L. Individual effects of dietary EPA and DHA on the functioning of the isolated working rat heart. Can J Physiol Pharmacol76:728–736, 1998.
40.
Gudbjarnason S, Oskarsdottir G. Changes in fatty acid composition of cardiac lipids accompanying myocardial necrosis. Recent Adv Stud Cardiac Struct Metab6:193–203, 1975.
41.
Hooper L, Thompson RL, Harrison RA, Summerbell CD, Ness AR, Moore HJ, Worthington HV, Durrington PN, Higgins JP, Capps NE, Riemersma RA, Ebrahim SB, Davey Smith G. Risks and benefits of omega 3 fats for mortality, cardiovascular disease, and cancer: systematic review. BMJ332:752–760, 2006.
42.
Yuan YV, Kitts DD. Dietary (n-3) fat and cholesterol alter tissue antioxidant enzymes and susceptibility to oxidation in SHR and WKY rats. J Nutr133:679–688, 2003.
43.
Gonzalez MJ, Gray JI, Schemmel RA, Dugan L Jr, Welsch CW. Lipid peroxidation products are elevated in fish oil diets even in the presence of added antioxidants. J Nutr122:2190–2195, 1992.
44.
Nishizuka Y. Intracellular signaling by hydrolysis of phospholipids and activation of protein kinase C. Science258:607–614, 1992.
45.
Koide H, Ogita K, Kikkawa U, Nishizuka Y. Isolation and characterization of the epsilon subspecies of protein kinase C from rat brain. Proc Natl Acad Sci U S A89:1149–1153, 1992.
46.
Blobe GC, Khan WA, Hannun YA. Protein kinase C: cellular target of the second messenger arachidonic acid? Prostaglandins Leukot Essent Fatty Acids 52:129–135, 1995.
47.
Damron DS, Bond M. Modulation of Ca2+ cycling in cardiac myocytes by arachidonic acid. Circ Res72:376–386, 1993.
48.
Damron DS, Darvish A, Murphy L, Sweet W, Moravec CS, Bond M. Arachidonic acid dependent phosphorylation of troponin I and myosin light chain kinase 2 in cardiac myocytes. Circ Res76:1011–1019, 1995.
49.
Huang XP, Pi Y, Lokuta AJ, Greaser ML, Walker JW. Arachidonic acid stimulates protein kinase C-epsilon redistribution in heart cells. J Cell Sci110:1625–1634, 1997.
50.
Murakami K, Chan SY, Routtenberg A. Protein kinase C activation by cis-fatty acid in the absence of Ca2+ and phospholipids. J Biol Chem261:15424–15429, 1986.
51.
Shirai Y, Kashiwagi K, Yagi K, Sakai N, Saito N. Distinct effects of fatty acids on translocation of gamma- and epsilon-subspecies of protein kinase C. J Cell Biol143:511–521, 1998.
52.
Eskildsen-Helmond YE, Hahnel D, Reinhardt U, Dekkers DH, Engelmann B, Lamers JM. Phospholipid source and molecular species composition of 1,2-diacylglycerol in agonist-stimulated rat cardiomyocytes. Cardiovasc Res40:182–190, 1998.
53.
Madani S, Hichami A, Legrand A, Belleville J, Khan NA. Implication of acyl chain of diacylglycerols in activation of different isoforms of protein kinase C. FASEB J15:2595–2601, 2001.
54.
Perletti G, Terrian DM. Distinctive cellular roles for novel protein kinase C isoenzymes. Curr Pharm Des12:3117–3133, 2006.
55.
Kashiwagi K, Shirai Y, Kuriyama M, Sakai N, Saito N. Importance of C1B domain for lipid messenger-induced targeting of protein kinase C. J Biol Chem277:18037–18045, 2002.
56.
Mackay K, Mochly-Rosen D. Arachidonic acid protects neonatal rat cardiac myocytes from ischaemic injury through epsilon protein kinase C. Cardiovasc Res50:65–74, 2001.
57.
Seung Kim HF, Weeber EJ, Sweatt JD, Stoll AL, Marangell LB. Inhibitory effects of omega-3 fatty acids on protein kinase C activity in vitro. Mol Psychiatry6:246–248, 2001.
58.
Mirnikjoo B, Brown SE, Kim HF, Marangell LB, Sweatt JD, Weeber EJ. Protein kinase inhibition by omega-3 fatty acids. J Biol Chem276:10888–10896, 2001.
59.
Takahashi R, Okumura K, Asai T, Hirai T, Murakami H, Murakami R, Numaguchi Y, Matsui H, Ito M, Murohara T. Dietary fish oil attenuates cardiac hypertrophy in lipotoxic cardiomyopathy due to systemic carnitine deficiency. Cardiovasc Res68:213–223, 2005.
60.
Nair SS, Leitch J, Garg ML. n-3 polyunsaturated fatty acid supplementation alters inositol phosphate metabolism and protein kinase C activity in adult porcine cardiac myocytes. J Nutr Biochem12:7–13, 2001.
61.
Sampath H, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. Nutr Rev62:333–339, 2004.
62.
Sessler AM, Ntambi JM. Polyunsaturated fatty acid regulation of gene expression. J Nutr128:923–926, 1998.
63.
Jump DB. Dietary polyunsaturated fatty acids and regulation of gene transcription. Curr Opin Lipidol13:155–164, 2002.
64.
Funari SS, Barcelo F, Escriba PV. Effects of oleic acid and its congeners, elaidic and stearic acids, on the structural properties of phosphatidylethanolamine membranes. J Lipid Res44:567–575, 2003.
65.
Escriba PV, Sastre M, Garcia-Sevilla JA. Disruption of cellular signaling pathways by daunomycin through destabilization of non-lamellar membrane structures. Proc Natl Acad Sci U S A92:7595–7599, 1995.
